Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Ori Biotech
company
About
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $100M
- Industries
- Biotechnology,Industrial Automation,Manufacturing,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$130M
Ori Biotech has raised a total of
$130M
in funding over 2 rounds. Their latest funding was raised on
Jan 18, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 18, 2022 | Series B | $100M | 1 | — | — | Detail |
| Oct 14, 2020 | Series A | $30M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Ori Biotech is funded by 1 investors.
Octopus Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Octopus Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
